Randomized Trial of Near-infrared Incisionless Fluorescent Cholangiography

Ann Surg. 2019 Dec;270(6):992-999. doi: 10.1097/SLA.0000000000003178.

Abstract

Background: Incisionless near-infrared fluorescent cholangiography (NIFC) is emerging as a promising tool to enhance the visualization of extrahepatic biliary structures during laparoscopic cholecystectomies.

Methods: We conducted a single-blind, randomized, 2-arm trial comparing the efficacy of NIFC (n = 321) versus white light (WL) alone (n = 318) during laparoscopic cholecystectomy. Using the KARL STORZ Image1 S imaging system with OPAL1 technology for NIR/ICG imaging, we evaluated the detection rate for 7 biliary structures-cystic duct (CD), right hepatic duct (RHD), common hepatic duct, common bile duct, cystic common bile duct junction, cystic gallbladder junction (CGJ), and accessory ducts -before and after surgical dissection. Secondary calculations included multivariable analysis for predictors of structure visualization and comparing intergroup biliary duct injury rates.

Results: Predissection detection rates were significantly superior in the NIFC group for all 7 biliary structures, ranging from 9.1% versus 2.9% to 66.6% versus 36.6% for the RHD and CD, respectively, with odds ratios ranging from 2.3 (95% CI 1.6-3.2) for the CGJ to 3.6 (1.6-9.3) for the RHD. After dissection, similar intergroup differences were observed for all structures except CD and CGJ, for which no differences were observed. Significant odds ratios ranged from 2.4 (1.7-3.5) for the common hepatic duct to 3.3 (1.3-10.4) for accessory ducts. Increased body mass index was associated with reduced detection of most structures in both groups, especially before dissection. Only 2 patients, both in the WL group, sustained a biliary duct injury.

Conclusions: In a randomized controlled trial, NIFC was statistically superior to WL alone visualizing extrahepatic biliary structures during laparoscopic cholecystectomy.

Registration number: NCT02702843.

Publication types

  • Randomized Controlled Trial

MeSH terms

  • Adult
  • Cholangiography*
  • Cholecystectomy, Laparoscopic / methods*
  • Female
  • Fluorescence
  • Fluorescent Dyes
  • Fluoroscopy*
  • Gallbladder Diseases / diagnostic imaging*
  • Gallbladder Diseases / surgery*
  • Humans
  • Indocyanine Green
  • Male
  • Middle Aged
  • Single-Blind Method

Substances

  • Fluorescent Dyes
  • Indocyanine Green

Associated data

  • ClinicalTrials.gov/NCT02702843